Biotech Boom Drives Lyophilisation

Contributor:  Andrea Charles
Posted:  08/05/2010  12:00:00 AM EDT
Rate this Article: (4.7 Stars | 56 Votes)

Biological shift

A growing biotechnology pipeline is fuelling the demand for lyophilisation technologies, and drug companies are looking to partner with contract manufacturing organisations (CMOs) which can assist them with lyophilising their increasing biological product range.

In a recent interview with Pharma IQ, Tim Nicholls, director at eXmoor pharma concepts said: ...

To continue viewing this content please fill out the form below and become an IQ member.
Already an IQ member? Sign in

First Name*
Last Name*
E-mail*
Phone*
Job Title*
Company*
Country
State
Username*
Password*
Confirm Password*
Andrea Charles Contributor:   Andrea Charles


comments powered by Disqus


Advertise With Us

Join the Pharmas IQ Community